Literature DB >> 195029

Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions.

L C Aschinberg, L M Solomon, P M Zeis, P Justice, I M Rosenthal.   

Abstract

A 5-year-old boy was found to have severe rickets in association with hyperpigmented, linear, verrucous, epidermal tumors, typical of the epidermal nevus syndrome. Normocalcemia (9.6 mg/dl), hypophosphatemia (2.0 mg/dl), elevated serum alkaline phosphatase concentration (313 IU), decreased renal tubular reabsorption of phosphorus (35%), radiologic evidence of rickets, and lack of response to usual therapeutic doses of vitamin D suggested hypophosphatemic vitamin D-resistant rickets. Therapy with vitamin D in doses to 750,000 IU and oral phosphate, 2.0 gm/day, failed to induce healing of the rickets. A subtotal parathyroidectomy performed when the patient was 9 years old was also without effect. When he was 12 years old several fibroangiomas on the face and left lower limb were excised. Within three months all biochemical abnormalities resolved and radiologic evidence of healing was observed. A portion of excised tissue was homogenized and injection of the supernate into a 6-week-old puppy induced excessive phosphaturia. The data suggest that the rickets was induced by a phosphaturic substance extractable from the tumors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 195029     DOI: 10.1016/s0022-3476(77)80444-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

Review 1.  The molecular background to hypophosphataemic rickets.

Authors:  P S Rowe
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

Review 2.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 3.  Lymphatic vessels are present in phosphaturic mesenchymal tumours.

Authors:  K Williams; A Flanagan; A Folpe; R Thakker; N A Athanasou
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

4.  Elevated FGF-23 and parathormone in linear nevus sebaceous syndrome with resistant rickets.

Authors:  Sidharth K Sethi; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2010-03-09       Impact factor: 3.714

Review 5.  Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.

Authors:  D Ovejero; Y H Lim; A M Boyce; R I Gafni; E McCarthy; T A Nguyen; L F Eichenfield; C M C DeKlotz; L C Guthrie; L L Tosi; P S Thornton; K A Choate; M T Collins
Journal:  Osteoporos Int       Date:  2016-08-06       Impact factor: 4.507

6.  Studies in a patient with tumor-induced hypophosphatemic osteomalacia.

Authors:  W G Ryan; S Gitelis; J R Charters
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

7.  Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23.

Authors:  Ryo Narazaki; Kenji Ihara; Noriyuki Namba; Hiroshi Matsuzaki; Keiichi Ozono; Toshiro Hara
Journal:  Pediatr Nephrol       Date:  2011-12-29       Impact factor: 3.714

Review 8.  DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.

Authors:  Luis F de Castro; Diana Ovejero; Alison M Boyce
Journal:  Eur J Endocrinol       Date:  2020-05       Impact factor: 6.664

Review 9.  X-linked hypophosphataemia: a homologous phenotype in humans and mice with unusual organ-specific gene dosage.

Authors:  C R Scriver; H S Tenenhouse
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 10.  Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.

Authors:  Young H Lim; Diana Ovejero; Kristina M Derrick; Michael T Collins; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2016-08       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.